The addition of acarbose to exercise, however, was associated with significant improvement of glycemic control and possibly cardiovascular risk factors.
Read More »Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Pl
Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Subjects whose postload plasma glucose concentration returned to baseline (i.e., FPG level) more quickly had greater insulin sensitivity, and a lower risk of developing type 2 diabetes.
Read More »Common Infections A Possible Link to Type 1 Diabetes
A major study has added weight to the theory that environmental factors such as common infections may be a trigger for diabetes in children and young adults’.
Read More »New Study Shows Cinnamon Lowers Blood Sugar Levels In type 2’s
A water-soluble, cinnamon extract has been shown to reduce fasting blood sugar levels in patients with type 2 diabetes, according to a new study from the University of Hannover in Hannover, Germany.
Read More »Kidney Stone Therapy Increases Risk for Hypertension and Diabetes
Beware! Shock wave lithotripsy (SWL) for renal calculi patients may increase the risk of hypertension and diabetes in long-term follow-up.
Read More »New ADA Recommendations Regarding Exercise and Type 2 Diabetes Issued
At least 150 minutes per week of moderate to vigorous physical activity and will vary according to goals. That is 30 minutes a day for 6 days a week.
Read More »Exenatide Reduces Insulin Use in Type 2 Diabetics
Exenatide therapy results in weight loss and a substantial decrease in insulin doses in some of the most difficult-to-manage patients with type 2 diabetes.
Read More »Diabetes Is The Clinical Equivlant of Aging 15 Years
Having diabetes can take away 15 years of a persons life. Diabetes is the clinical equivalent of aging 15 years, thrusting men and women with the disease into a high-risk category for cardiovascular disease while still in middle-age.
Read More »ADA: Investigational Drug Produces Significant Weight Loss for Obese
Investigators reported that — Lorcaserin, an investigational drug for the treatment of obesity, produced weight losses between four and 7.9 pounds (1.8 to 3.6 kg) in a 12-week phase IIb dose-ranging study.
Read More »Parental Perceptions of Diabetes in Their Children Are Significantly Related to
Study showed that poorer glycemic control in childhood diabetes could result from both lower perceived seriousness of the condition and higher than warranted perceived competence of the child.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.